For many people navigating the stresses of the COVID-19 pandemic, temporary relief came in the form of a stiff drink. In the United States, the pandemic years were accompanied by the largest increase ...

The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide has made headlines as a US Food and Drug Administration (FDA)–approved treatment for type 2 diabetes (Ozempic) and obesity (Wegovy).

Substance use disorders (SUDs) in oncology populations represent a significant yet underrecognized challenge, with prior research suggesting that up to 27 percent of cancer patients meet criteria for ...

Share on Pinterest Research suggests that GLP-1 drugs like Ozempic and Wegovy could help curb alcohol cravings in people with alcohol use disorder. Stefa Nikolic/Getty Images A new study suggests that ...

Alcohol, tobacco and substance use are common among young adults; problematic alcohol use is especially prevalent on college campuses. There are a variety of factors that influence individual patterns ...